208. Corrected transposition of great arteries Disease details / Clinical trials / Drug dev / DR info /


Clinical trials : 2 /  Drugs : 2 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Diovan
   Novartis Pharma B.V.
      2006   Phase 3   EUCTR2006-002262-19-NL   Netherlands
SGLT2 inhibitors
   Leiden University Medical Center
      2023   -   NCT06932081   Germany;Netherlands;North Macedonia;United Kingdom;United States